WO2016033326A2 - Methods of treating transthyretin (ttr) mediated amyloidosis - Google Patents

Methods of treating transthyretin (ttr) mediated amyloidosis Download PDF

Info

Publication number
WO2016033326A2
WO2016033326A2 PCT/US2015/047185 US2015047185W WO2016033326A2 WO 2016033326 A2 WO2016033326 A2 WO 2016033326A2 US 2015047185 W US2015047185 W US 2015047185W WO 2016033326 A2 WO2016033326 A2 WO 2016033326A2
Authority
WO
WIPO (PCT)
Prior art keywords
ttr
composition
administered
nis
patisiran
Prior art date
Application number
PCT/US2015/047185
Other languages
French (fr)
Other versions
WO2016033326A3 (en
Inventor
Brian Bettencourt
Original Assignee
Alnylam Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201462044100P priority Critical
Priority to US62/044,100 priority
Priority to US201562150596P priority
Priority to US62/150,596 priority
Application filed by Alnylam Pharmaceuticals, Inc. filed Critical Alnylam Pharmaceuticals, Inc.
Publication of WO2016033326A2 publication Critical patent/WO2016033326A2/en
Publication of WO2016033326A3 publication Critical patent/WO2016033326A3/en

Links